Foto del docente

Andrea Ardizzoni

Full Professor

Department of Medical and Surgical Sciences

Academic discipline: MEDS-09/A Medical Oncology

Head of Scuola di Specializzazione Oncologia Medica (DI 68/2015)

Teaching

Recent dissertations supervised by the teacher.

Single cycle degree programmes dissertations

  • Beyond BRAF mutation in advanced melanoma patients treated with immune-checkpoint inhibitors
  • Fattori predittivi clinici e molecolari in pazienti affetti da carcinoma del polmone non a piccole cellule EGFR-mutato trattati in prima linea con osimertinib
  • Fattori prognostici dei carcinoidi tipici ed atipici del polmone. Studio osservazionale retrospettivo monocentrico
  • Impatto delle terapie concomitanti in pazienti affetti da NSCLC avanzato in trattamento con chemio-immunoterapia
  • studio osservazionale di chemio-immunoterapia di salvataggio in pazienti con non-small cell lung cancer (nsclc) in stadio avanzato e pd-l1 ≥ 50% in rapida progressione a immunoterapia di prima linea: esperienza dell’irccs azienda ospedaliero-universitaria di bologna
  • Terapie antiblastiche sistemiche negli ultimi 30 giorni di vita: analisi retrospettiva di pazienti ricoverati in degenza oncologica
  • The role of tertiary lymphoid structures as a prognostic biomarker for upfront immunotherapy single agent or in combination with chemotherapy for advanced NSCLC
  • Utilizzo della ablazione percutanea con radiofrequenza (RFA) nel trattamento delle metastasi epatiche nei Tumori Stromali Gastrointestinali (GIST) - uno studio retrospettivo monocentrico

Specialisation Schools dissertations

  • An open-label, randomized phase III study of Early switch maintenance vs Delayed second-line Nivolumab in advanced stage squamous non-small cell lung cancer (NSCLC) patients after standard first-line platinum-based chemotherapy-EDEN trial GOIRC 04-2016
  • Genomic profiling in the diagnosis and treatment of Cancer of Unknown Primary (CUP)
  • the role of tert promoter mutations in advanced melanoma patients treated with braf/mek inhibitors or immunotherapy: a single-centre retrospective analysis
  • Trattamento neoadiuvante dell’adenocarcinoma del pancreas: revisione sistematica dei dati di letteratura con metanalisi degli studi clinici controllati
  • TTF-1 expression identifies subtypes of lung adenocarcinoma with distinct features and response to treatments

PhD programmes thesis

  • A prospective study on the early evaluation of response to androgen receptor-targeted agents with 11C-Choline, 68Ga-PSMA and 18F-FACBC PET in metastatic castration-resistant prostate cancer: a single center experience.
  • Identification of alternative strategies in advanced non-small cell lung cancer (NSCLC) patients resistant to immune checkpoint inhibitors (ICIs) or with rare histologies
  • The RAS-Lung project: implementing blood and tissue genotyping in KRAS-Positive non-small cell lung cancer treatment